Literature DB >> 10570093

Urothelial cancer at different tumour sites: role of smoking and habitual intake of analgesics and laxatives. Results of the Berlin Urothelial Cancer Study.

W Pommer1, E Bronder, A Klimpel, U Helmert, E Greiser, M Molzahn.   

Abstract

BACKGROUND: In Germany about 20000 new cases of urothelial cancer (UC) and about 7500 deaths from bladder cancer alone occur each year. Among the manifold risk factors, little research has been done on the role of smoking and the habitual intake of analgesics and laxatives-practices that are common in parts of the German population. The aim of this study is to define the proportion of risk derived from these preventable habits for the development of UC at its different sites. Subjects and methods. A case-control study in the area of the former West Berlin was performed from 1990 to 1995 including all newly diagnosed incident cases of UC from the eight hospitals of the study area. Study subjects and population-based controls individually matched by age (+/-2 years) and sex were evaluated by a standardized face-to-face interview about the lifelong exposure to cigarette smoking, analgesics, and laxatives. Adjusted risk analysis was carried out for the main exposure variables in relation to the different sites of UC in the bladder, ureter, and renal pelvis.
RESULTS: Six hundred and forty-seven cases of UC (571 bladder, 25 ureter, and 51 renal pelvis) and an identical number of controls were included in the analysis (response rate in cases, 84.6%; in controls, 70.2%). Smoking increased the risk of bladder cancer (BC) by an odds ratio (OR) of 3.22 (95% confidence interval (CI) 2.29-4.52), that of ureter (URC) or renal pelvis cancer (RPC) together by OR 6.20 (95% CI 2.04-18.81), and that of RPC alone by OR 5.91 (95% CI 1.47-23.66). Ex-smoking was associated with an increased risk for BC (OR 1.55, 95% CI 1.10-2.19). Intake of more than 1 kg of phenacetin in analgesic mixtures was associated with an OR of 5.28 for RPC (intake of > or = 1 kg paracetamol, OR 3.27; > or = 1 kg pyrazolones, 1.12) and 0.75 for BC (not significant). Laxatives significantly increased the risk of BC (OR 2.14, 95% CI 1.26-3.63) and RPC/URC (OR 9.62, 95% CI 1. 01-91.24) in both sexes.
CONCLUSION: Habitual risks from smoking and intake of laxatives significantly contribute to the development of UC, especially of the renal pelvis and ureter cancer. Intake of at least 1 kg of analgesic substances (anilides, pyrazolones) as calculated from this study base is associated with increased but not significant risks for RPC. These data underline that restrictive and educational measurements focusing on common habits would have a strong impact on preventing UC in Germany.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10570093     DOI: 10.1093/ndt/14.12.2892

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  18 in total

Review 1.  Chemoprevention of bladder cancer.

Authors:  Dragan J Golijanin; David Kakiashvili; Ralph R Madeb; Edward M Messing; Seth P Lerner
Journal:  World J Urol       Date:  2006-11       Impact factor: 4.226

2.  HAS3 underexpression as an indicator of poor prognosis in patients with urothelial carcinoma of the upper urinary tract and urinary bladder.

Authors:  I-Wei Chang; Peir-In Liang; Ching-Chia Li; Wen-Jeng Wu; Chun-Nung Huang; Victor Chia-Hsiang Lin; Chao-Tien Hsu; Hong-Lin He; Ting-Feng Wu; Chih-Hsin Hung; Chien-Feng Li
Journal:  Tumour Biol       Date:  2015-05-02

3.  CDCA5 overexpression is an indicator of poor prognosis in patients with urothelial carcinomas of the upper urinary tract and urinary bladder.

Authors:  I-Wei Chang; Victor Chia-Hsiang Lin; Hong-Lin He; Chao-Tien Hsu; Ching-Chia Li; Wen-Jeng Wu; Chun-Nung Huang; Ting-Feng Wu; Chien-Feng Li
Journal:  Am J Transl Res       Date:  2015-04-15       Impact factor: 4.060

Review 4.  Nonsteroidal antiinflammatory drugs and bladder cancer: a pooled analysis.

Authors:  Sarah E Daugherty; Ruth M Pfeiffer; Alice J Sigurdson; Richard B Hayes; Michael Leitzmann; Arthur Schatzkin; Albert R Hollenbeck; Debra T Silverman
Journal:  Am J Epidemiol       Date:  2011-03-02       Impact factor: 4.897

5.  Long-term use of acetaminophen, aspirin, and other nonsteroidal anti-inflammatory drugs and risk of hematologic malignancies: results from the prospective Vitamins and Lifestyle (VITAL) study.

Authors:  Roland B Walter; Filippo Milano; Theodore M Brasky; Emily White
Journal:  J Clin Oncol       Date:  2011-05-09       Impact factor: 44.544

6.  Population-based case-control study of Chinese herbal products containing aristolochic acid and urinary tract cancer risk.

Authors:  Ming-Nan Lai; Shuo-Meng Wang; Pau-Chung Chen; Ya-Yin Chen; Jung-Der Wang
Journal:  J Natl Cancer Inst       Date:  2009-12-21       Impact factor: 13.506

7.  A commentary on "risk factors for renal cell cancer in a Japanese population".

Authors:  Esther Uña Cidon
Journal:  Clin Med Oncol       Date:  2009-08-14

8.  Impact of smoking on oncologic outcomes of upper tract urothelial carcinoma after radical nephroureterectomy.

Authors:  Michael Rink; Evanguelos Xylinas; Vitaly Margulis; Eugene K Cha; Behfar Ehdaie; Jay D Raman; Felix K Chun; Kazumasa Matsumoto; Yair Lotan; Helena Furberg; Marek Babjuk; Armin Pycha; Christopher G Wood; Pierre I Karakiewicz; Margit Fisch; Douglas S Scherr; Shahrokh F Shariat
Journal:  Eur Urol       Date:  2012-06-22       Impact factor: 20.096

9.  Long-term NSAID use and incident urothelial cell carcinoma in the VITamins and Lifestyle (VITAL) study.

Authors:  Cheryl Shih; James M Hotaling; Jonathan L Wright; Emily White
Journal:  Urol Oncol       Date:  2012-07-12       Impact factor: 3.498

Review 10.  Epidemiology of urinary bladder cancer: from tumor development to patient's death.

Authors:  Cristiane Murta-Nascimento; Bernd J Schmitz-Dräger; Maurice P Zeegers; Gunnar Steineck; Manolis Kogevinas; Francisco X Real; Núria Malats
Journal:  World J Urol       Date:  2007-06       Impact factor: 3.661

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.